Page 27 - HFA Dateline 2022 Special Edition
P. 27
CURRENT PRODUCTS • BY THE NUMBERS
43 Approved Products
DISTRIBUTION PRODUCTS BY TYPE
OF PRODUCTS BY
MANUFACTURER 56% 28%
Takeda .................................... 8 Recombinant Plasma-derived
clotting factor clotting factor
CSL Behring .......................... 5
Novo Nordisk ........................ 5 14% 2%
Pfizer .......................................4 Non-factor Bi-specific
Bayer ....................................... 3 product antibody
Ferring Pharmaceuticals .... 3
NUMBER OF
Grifols ..................................... 3
PRODUCTS BY
Octapharma .......................... 3 INDICATION
Sanofi ...................................... 2 23 7
Akorn Pharmaceuticals .......1
Bio Products Laboratory .....1 Factor VIII VWD
9 7
Dr. Reddy’s Laboratories ....1
Genentech ..............................1
Factor IX Rare
HEMA Biologics .....................1
Kedrion Biopharma ..............1 4 2
Medexus ..................................1 Inhibitor Other
MOST RECENTLY RELEASED PRODUCTS
YEAR RELEASED PRODUCT INDICATION MANUFACTURER
2020 Sevenfact Inhibitor HEMA Biologics
Desmopressin Acetate Injection Factor VIII; Dr. Reddy’s
2020
USP (desmopressin acetate) VWD Laboratories
2019 Novo Nordisk Factor VIII ESPEROCT
2018 Bayer Factor VIII Jivi
Special Issue 2022 27
